Prevalence, incidence, and treatment trends of adenomyosis in South Korean women for 15 years: A national population‐based study

Abstract

AbstractObjectiveAdenomyosis is associated with female infertility worldwide. With improvements in imaging methods, such as pelvic magnetic resonance imaging, the diagnosis and treatment of adenomyosis have changed. This study aimed to evaluate the overall prevalence, incidence, and treatment trends of adenomyosis in South Korea using data from the Korean National Health Insurance Service Database (NHIS).MethodsData were collected from the Korean NHIS, a population‐based complete enumeration database. A total of 678 641 women aged 11–55 years diagnosed with adenomyosis (N80.0 ICD‐10 code) from the database from 2002 to 2016 were enrolled. After applying a one‐year look‐back method, 629 592 patients were analyzed to estimate the prevalence, incidence, and treatment trends of adenomyosis.ResultsThe overall prevalence during the study period was 3.86 per 1000 people. The prevalence of adenomyosis has increased from 1.42 per 1000 individuals in 2002 to 7.50 per 1000 individuals in 2016. The crude annual incidence rate of adenomyosis was 1.62 per 1000 people in 2003, which increased to 4.12 per 1000 people in 2016. In addition, the proportion of uterus‐preserving surgeries in adenomyosis treatments has increased from 7.51% to 21.29% over 15 years.ConclusionThe prevalence and incidence of adenomyosis in South Korea increased between 2002 and 2016. Furthermore, the proportion of uterus‐preserving surgeries and progestin prescriptions for adenomyosis treatment has increased. We expect that our findings will raise awareness of the necessity for fertility preservation through earlier diagnosis and proper management of patients with adenomyosis.